Showing 20 of 32 recruiting trials for “fulminant-viral-hepatitis”
Phase 2b/3 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide
RecruitingNCT07491848 ↗
Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D
A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)
RecruitingNCT07317011 ↗
"Referral Attivo" Delta, Dallo Screening Alla Presa in Carico.
👨⚕️ Eleonora Sfreddo, FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS📍 3 sites📅 Started Oct 2025View details ↗
RecruitingNCT07429864 ↗
Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide
👨⚕️ Francesca Romana Ponziani, Fondazione Policlinico A. Gemelli IRCCS📍 1 site📅 Started Sep 2025View details ↗
A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)
Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus
A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide
RecruitingNCT07442760 ↗
ePro Diary - HDV ( MACROLIVER )
Continuous Renal Replacement Therapy Intensity in Hyperammonemia
Standard Volume vs. High Volume Plasma Exchange in Pediatric Acute Liver Failure
RecruitingNCT06889805 ↗
HDV Screening Study
RecruitingNCT06908746 ↗
Efficacy and Safety of Citrate Anticoagulation in CRRT for Patients With Liver Failure/DysfuncTION, the CAUTION Trial! A Retrospective Study on Etiology of Liver Failure and Their Complications
Enrolling by InvitationNCT06893042 ↗
Clinical Study of Pediatric Acute Liver Failure
RecruitingNCT06504485 ↗
Immunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Response to Bulevirtide Treatment
🏥 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico📍 1 site📅 Started Sep 2024View details ↗
RecruitingNCT06397859 ↗
Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated Cirrhosis
🏥 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico📍 1 site📅 Started May 2024View details ↗
RecruitingNCT06264583 ↗
HDV-Europe: Prevalence and Outcome of HDV in HIV/HBV Coinfection
ALSS - DPMAS and Therapeutic Plasma Exchange (TPE), Its Effect on Primary Coagulation, Inflammation and the Function of Vital Organs in ALF or ACLF
RecruitingNCT06248580 ↗
Find HDV and Determine Its Status in Turkey
👨⚕️ Mustafa Kemal Çelen, MD, Dicle University, Medical Faculty, Department of Infectious Diseases📍 2 sites📅 Started Mar 2024View details ↗
RecruitingNCT05903742 ↗
Standardising Care for Hepatitis Delta in the Netherlands
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →